Health Information

Health Education

:::

Instructions for Meningitidis Group B Vaccination B型腦膜炎雙球菌疫苗接種須知

Qrcode
Print
A-
A+

Instructions for Meningitidis Group B Vaccination B型腦膜炎雙球菌疫苗接種須知

2024/11/18

Introduction to Neisseria meningitidis

Neisseria meningitidis could lead to meningococcal meningitis. Although it is a not a common disease, it still has a considerably high severity rate and mortality rate. Without the correct and timely medicinal administration, one in every 2 patients could die. Even with the correct administration, 1/10 of patients could still die while 30% of the survivors could suffer from long-term sequela (i.e.: hearing loss, epilepsy, neurological dysfunction, or finger/limb amputation).

Prevention

Receive meningitidis Group B vaccination and keep personal hygiene and wear face masks in high-risk areas. Avoid getting in contact with patients of respiratory diseases.

Recommended vaccination schedule

Age for first dose
Primary immunization
Interval between primary dose
Booster Dose
2 to 5 months old
2 doses
Not less than 2 months
One dose should be administered at 12 and 15 months of age, with an interval of at least 6 months between the primary series and the booster dose.
3 doses
Not less than 1 month
6 to 11 months old
2 doses
Not less than 2 months
One dose should be administered in the second year of life, with an interval of at least 2 months between the primary series and the booster dose.
12 to 23 months old
2 doses
Not less than 2 months
One dose should be administered, with an interval of 12 to 23 months between the primary series and the booster dose.
2 years old and above or adults
2 doses
Not less than 1 month
According to official recommendations, a booster dose should be considered for individuals at ongoing risk of exposure to meningococcal disease.

Common Adverse Reactions

Including eating disorders, drowsiness, abnormal crying, headache, diarrhea, vomiting (rarely after receiving a booster dose), rash (in children aged 12 to 23 months) (rarely after receiving a booster dose), joint pain, fever (≧ 38°C), agitation, and tenderness, redness, swelling, and nodules on the injection site.

若有任何疑問,請不吝與我們聯絡
電話:(04) 22052121 分機 12128、12132、12135
HE-50119-E
}
Stay connected with CMUH
How to get to CMUH the map of hospital